Remove 2030 Remove Pharma Companies Remove Therapies
article thumbnail

Women in STEM with Gilda Ascione

Drug Target Review

At the beginning of my career, during my scholarship, I worked for two years at a research institute where I set up a research project focused on the study of metronomic oral therapies for patients with metastatic breast cancer (BC). That paper, of which I was in the authorship, remains a current point of reference for that therapy usage.

Doctors 97